These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29554887)

  • 1. CircRNAs as biomarkers of cancer: a meta-analysis.
    Wang M; Yang Y; Xu J; Bai W; Ren X; Wu H
    BMC Cancer; 2018 Mar; 18(1):303. PubMed ID: 29554887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormally Expressed Circular RNAs are Promising Biomarkers for Diagnosis of Hepatocellular Carcinoma: a Meta-Analysis.
    Yu G; Yang L; Zhou J; Zhang L; Xia L
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Zhang C; Zhang C; Lin J; Wang H
    Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of circRNAs in the Diagnosis of Colorectal Cancer: A Meta-Analysis.
    Li RD; Guan M; Zhou Z; Dong SX; Liu Q
    Front Med (Lausanne); 2021; 8():766208. PubMed ID: 34869475
    [No Abstract]   [Full Text] [Related]  

  • 5. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
    Hao Q; Han Y; Xia W; Wang Q; Qian H
    Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinomaļ¼ša meta-analysis.
    Zhang H; Ding R; Chen D
    Biomarkers; 2021 Nov; 26(7):586-597. PubMed ID: 34266326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta-analysis.
    Huang X; Zhang W; Shao Z
    Cancer Med; 2019 Mar; 8(3):1148-1156. PubMed ID: 30693679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNAs as biomarkers for the diagnosis of hepatocellular carcinoma: A meta-analysis.
    Zeng C; Tang Y; Jiang Y; Zuo Z; Tao H
    Pathol Res Pract; 2021 Aug; 224():153546. PubMed ID: 34332221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
    Hao QQ; Chen GY; Zhang JH; Sheng JH; Gao Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7496. PubMed ID: 28700498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis.
    Chen S; Zhang Y; Wu X; Zhang C; Li G
    Can J Gastroenterol Hepatol; 2018; 2018():8410195. PubMed ID: 30410873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of CircRNAs as Potential Biomarkers in Oral Squamous Cell Carcinoma: a Meta-Analysis.
    Wang M; Zhang L; Ren W; Li S; Zhi K; Zheng J; Gao L
    Front Oncol; 2021; 11():693284. PubMed ID: 34307158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
    Zheng C; Hao H; Chen L; Shao J
    Clin Transl Oncol; 2017 Aug; 19(8):961-968. PubMed ID: 28188488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
    Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Circulating Cell-free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-analysis.
    Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
    Curr Med Chem; 2024; 31(22):3345-3359. PubMed ID: 37349993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literature.
    Yang SL; Fang X; Huang ZZ; Liu XJ; Xiong ZF; Liu P; Yao HY; Li CH
    Dis Markers; 2014; 2014():127831. PubMed ID: 25378766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma.
    Qin M; Liu G; Huo X; Tao X; Sun X; Ge Z; Yang J; Fan J; Liu L; Qin W
    Cancer Biomark; 2016; 16(1):161-9. PubMed ID: 26600397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.
    Chu M; Fang Y; Jin Y
    J Clin Lab Anal; 2021 Sep; 35(9):e23934. PubMed ID: 34331339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNAs as diagnostic biomarkers in gastric cancer: A meta-analysis review.
    Jiang F; Hong F; Shah MW; Shen X
    Pathol Res Pract; 2019 Jun; 215(6):152419. PubMed ID: 31043351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M
    Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
    Yu J; Wang ZJ; Chen LH; Dong WZ
    Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.